BMC Collection: Hepatitis C

The 2020 Nobel Prize for Physiology or Medicine was awarded on the 5th of October to Harvey J. Alter, Michael Houghton and Charles M. Rice for their discovery of Hepatitis C virus. In celebration of what they started and showcasing areas of research that have since emerged, we here present a collection of articles from the BMC Biology, BMC Medicine, Genome Medicine and the BMC Series Journals on biology, diagnosis and treatment and wider public health and medical outcomes of the Hepatitis C virus and its infection.

Viral biology and biology of infection:

Viral hijacking of cellular metabolism
Shivani K. Thaker, James Ch’ng & Heather R. Christofk
Review | BMC Biology 17: 59 (2019)
Full text PDF

Development and biological activity of long-acting recombinant human interferon-α2b
Qian Zhang, Chao Wang, Fenlian Ma, Lihong Yao, Hanchun Gao, Luyan Zhu & Lishu Zheng
Research article | BMC Biotechnology 20: 16 (2020)
Full text PDF

Effects of hepatitis C virus core protein and nonstructural protein 4B on the Wnt/β-catenin pathway
Xiao-Hua Jiang, Yu-Tao Xie, Ya-Ping Cai, Jing Ren & Tao Ma
Research article | BMC Microbiology 17: 124 (2017)
Full text PDF

Production of infectious HCV genotype 1b virus in cell culture using a novel Set of adaptive mutations
Ken-ichi Mori, Akihiro Matsumoto, Noboru Maki, Yuki Ichikawa, Eiji Tanaka & Shintaro Yagi
Research article | BMC Microbiology 16: 224 (2016)
Full text        PDF

HCVIVdb: The hepatitis-C IRES variation database
Evan W. Floden, Anas Khawaja, Václav Vopálenský & Martin Pospíšek
Database | BMC Microbiology 16: 187 (2016)
Full text        PDF

Common molecular mechanism of the hepatic lesion and the cardiac parasympathetic regulation in chronic hepatitis C infection: a critical role for the muscarinic receptor type 3
Sanja Glišić, David P. Cavanaugh, Krishnan K. Chittur, Milan Sencanski, Vladimir Perovic & Tijana Bojić
Research article | BMC Bioinformatics 17: 139 (2016)
Full text PDF

Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort
Katherine R Smith, Vijayaprakash Suppiah, Kate O'Connor, Thomas Berg, Martin Weltman, Maria Lorena Abate, Ulrich Spengler, Margaret Bassendine, Gail Matthews, William L Irving, Elizabeth Powell, Stephen Riordan, Golo Ahlenstiel, Graeme J Stewart, Melanie Bahlo, Jacob George, David R Booth & the International Hepatitis C Genetics Consortium (IHCGC)
Research article | Genome Medicine 3: 57 (2011)
Full text PDF

The mode and tempo of hepatitis C virus evolution within and among hosts
Rebecca R Gray, Joe Parker, Philippe Lemey, Marco Salemi, Aris Katzourakis & Oliver G Pybus
Research article | BMC Evolutionary Biology 11: 131 (2011)
Full text        PDF

The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry
Vera Rocha-Perugini, Muriel Lavie, David Delgrange, Jonathan Canton, André Pillez, Julie Potel, Cécile Lecoeur, Eric Rubinstein, Jean Dubuisson, Czeslaw Wychowski & Laurence Cocquerel
Research article | BMC Microbiology 9: 111 (2009)
Full text        PDF

Diagnosis and treatment:

Beyond clinical outcomes: the social and healthcare system implications of hepatitis C treatment
Marta Torrens, Tokunbo Soyemi, Darcy Bowman & Eberhard Schatz
Research article | BMC Infectious Diseases 20: 702 (2020) Sep 20
Full text PDF

Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants
Curtis L. Cooper, Daniel Read, Marie-Louise Vachon, Brian Conway, Alexander Wong, Alnoor Ramji, Sergio Borgia, Ed Tam, Lisa Barrett, Dan Smyth, Jordan J. Feld, Sam Lee & on behalf of the CANUHC Cohort
Research article | BMC Public Health 20: 1345 (2020)
Full text        PDF

Aflatoxins as a risk factor for liver cirrhosis: a systematic review and meta-analysis
Abraham Nigussie Mekuria, Michael N. Routledge, Yun Yun Gong & Mekonnen Sisay
Research article | BMC Pharmacology and Toxicology 21: 39 (2020)
Full text        PDF

Treatment outcomes of patients with chronic hepatitis C receiving sofosbuvir-based combination therapy within national hepatitis C elimination program in the country of Georgia
Tengiz Tsertsvadze, Amiran Gamkrelidze, Muazzam Nasrullah, Lali Sharvadze, Juliette Morgan, Shaun Shadaker, Lia Gvinjilia, Maia Butsashvili, David Metreveli, Vakhtang Kerashvili, Marina Ezugbaia, Nikoloz Chkhartishvili, Akaki Abutidze, Valeri Kvaratskhelia & Francisco Averhoff
Research article | BMC Infectious Diseases 20: 30 (2020)
Full text PDF

A systematic review and meta-analysis of community and primary-care-based hepatitis C testing and treatment services that employ direct acting antiviral drug treatments
Andrew Radley, Emma Robinson, Esther J. Aspinall, Kathryn Angus, Lex Tan & John F. Dillon
Research article | BMC Health Services Research 19: 765 (2019)
Full text PDF

The case for a universal hepatitis C vaccine to achieve hepatitis C elimination
Nick Scott, David P. Wilson, Alexander J. Thompson, Eleanor Barnes, Manal El-Sayed, Adele Schwartz Benzaken, Heidi E. Drummer & Margaret E. Hellard
Research article | BMC Medicine 17: 175 (2019)
Full text PDF

Usefulness of automated assays for detecting hepatitis B and C markers in dried blood spot samples
Livia Melo Villar, Helena Medina Cruz, Raissa Martins Deodato, Juliana Custódio Miguel, Elisangela Ferreira da Silva, Geane Lopes Flores & Lia Laura Lewis-Ximenez
Research note | BMC Research Notes 12: 523 (2019)
Full text PDF

Detection of virus-specific polymeric immunoglobulin A in acute hepatitis A, C, E virus serum samples using novel chimeric secretory component
Khayriyyah Mohd Hanafiah, Mary L. Garcia, Nadine C. Barnes & David A. Anderson
Research note | BMC Research Notes 11: 688 (2018)
Full text PDF

Cost-effectiveness of diagnostic and therapeutic interventions for chronic hepatitis C: a systematic review of model-based analyses
Rodolfo Castro, Louise Crathorne, Hugo Perazzo, Julio Silva, Chris Cooper, Jo Varley-Campbell, Daniel Savignon Marinho, Marcela Haasova, Valdilea G. Veloso, Rob Anderson & Chris Hyde
Research article | BMC Medical Research Methodology 18: 53 (2018)
Full text PDF

Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran’s Affairs Health Care System
Nabihah Tayob, Peter Richardson, Donna L. White, Xiaoying Yu, Jessica A. Davila, Fasiha Kanwal, Ziding Feng & Hashem B. El-Serag
Research article | BMC Medical Research Methodology 18: 1 (2018)
Full text PDF

Synthesis and biological evaluation of tricyclic matrinic derivatives as a class of novel anti-HCV agents
Sheng Tang, Zong-Gen Peng, Ying-Hong Li, Xin Zhang, Tian-Yun Fan, Jian-Dong Jiang, Yan-Xiang Wang & Dan-Qing Song
Research article | Chemistry Central Journal (BMC Chemistry) 11: 94 (2017)
Full text PDF

Simultaneous determination of newly developed antiviral agents in pharmaceutical formulations by HPLC-DAD
Nourah Zoman Al-Zoman, Hadir Mohamed Maher & Amal Al-Subaie
Research article | Chemistry Central Journal (BMC Chemistry) 11: 1 (2017)
Full text PDF

Rapid metagenomic identification of viral pathogens in clinical samples by real-time nanopore sequencing analysis
Alexander L. Greninger, Samia N. Naccache, Scot Federman, Guixia Yu, Placide Mbala, Vanessa Bres, Doug Stryke, Jerome Bouquet, Sneha Somasekar, Jeffrey M. Linnen, Roger Dodd, Prime Mulembakani, Bradley S. Schneider, Jean-Jacques Muyembe-Tamfum, Susan L. Stramer & Charles Y. Chiu
Method | Genome Medicine 7: 99 (2015)
Full text PDF

Peretinoin, an acyclic retinoid, improves the hepatic gene signature of chronic hepatitis C following curative therapy of hepatocellular carcinoma
Masao Honda, Taro Yamashita, Tatsuya Yamashita, Kuniaki Arai, Yoshio Sakai, Akito Sakai, Mikiko Nakamura, Eishiro Mizukoshi & Shuichi Kaneko
Research article | BMC Cancer 13: 191 (2013)
Full text PDF

Pharmacogenomics of hepatitis C infections: personalizing therapy
David R Booth, Golo Ahlenstiel & Jacob George
Review | Genome Medicine 4: 99 (2012)
Full text PDF

Medical and Public health outcomes:

Hepatitis C in the criminal justice system: opportunities for global action in the era of viral hepatitis elimination
Matthew J. Akiyama
Commentary | BMC Medicine 18: 208 (2020)
Full text PDF

Prevalence of hepatitis C in the adult population of Bulgaria: a pilot study
Ida Sperle, Stine Nielsen, Martyna Gassowski, Zlatina Naneva, Tanya Perchemlieva, Andrew Amato-Gauci, Matthias an der Heiden, Viviane Bremer, Elitsa Golkocheva-Markova, Kristiyan Hristov, Elena Kaneva, Yanita Simeonova, Tencho Tenev, Tonka Varleva, Erika Duffell & Ruth Zimmermann
Research note | BMC Research Notes 13: 326 (2020)
Full text PDF

Patient and healthcare provider experiences of hepatitis C treatment with direct-acting antivirals in Rwanda: a qualitative exploration of barriers and facilitators
Janvier Serumondo, Michael J. Penkunas, Julienne Niyikora, Alida Ngwije, Athanase Kiromera, Emmanuel Musabeyezu, Justine Umutesi, Sabine Umuraza, Gentille Musengimana & Sabin Nsanzimana
Research article | BMC Public Health 20: 946 (2020)
Full text PDF

Clients’ perceptions of barriers and facilitators to implementing hepatitis C virus care in homeless shelters
Carmen L. Masson, J. Konadu Fokuo, August Anderson, Jesse Powell, Barry Zevin, Dylan Bush & Mandana Khalili
Research article | BMC Infectious Diseases 20: 386 (2020)
Full text PDF

Eliminating viral hepatitis C in Belgium: the micro-elimination approach
Dana Busschots, Samira Toghanian, Rob Bielen, Stina Salomonsson, Özgür M. Koc, Greet Hendrickx, Michel Jadoul, Frederik Nevens, Etienne Sokal, Christian Brixko, Kathelijne Peerlinck, Ludwig Apers, Geert Robaeys & Jeffrey V. Lazarus
Research article | BMC Infectious Diseases 20: 181 (2020)
Full text PDF

Hepatitis C virus genotype affects survival in patients with hepatocellular carcinoma
Hye Kyong Park, Sang Soo Lee, Chang Bin Im, Changjo Im, Ra Ri Cha, Wan Soo Kim, Hyun Chin Cho, Jae Min Lee, Hyun Jin Kim, Tae Hyo Kim, Woon Tae Jung & Ok-Jae Lee
Research article | BMC Cancer 19: 822 (2019)
Full text PDF

Linkage to hepatitis C care after incarceration in jail: a prospective, single arm clinical trial
Matthew J. Akiyama, Devin Columbus, Ross MacDonald, Alison O. Jordan, Jessie Schwartz, Alain H. Litwin, Benjamin Eckhardt & Ellie Carmody
Research article | BMC Infectious Diseases 19: 703 (2019)
Full text PDF

Improving engagement with healthcare in hepatitis C: a randomised controlled trial of a peer support intervention
Helen R. Stagg, Julian Surey, Marie Francis, Jennifer MacLellan, Graham R. Foster, André Charlett & Ibrahim Abubakar
Research article | BMC Medicine 17: 71 (2019)
Full text PDF

Short-term budget affordability of hepatitis C treatments for state Medicaid programs
Jacquelyn W. Chou, Alison R. Silverstein & Dana P. Goldman
Research article | BMC Health Services Research 19: 140 (2019)
Full text PDF

The HCV Synthesis Project: Scope, methodology, and preliminary results
Rebecca K Stern, Holly Hagan, Corina Lelutiu-Weinberger, Don Des Jarlais, Roberta Scheinmann, Shiela Strauss, Enrique R Pouget & Peter Flom
Research article | BMC Medical Research Methodology 8: 62 (2008)
Full text PDF